BeOne Medicines (BEIGF) Property, Plant & Equipment (Net) (2015 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | 23.58 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | 5.80 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | 25.74 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | 10.69 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 19.03 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 34.61 Mn |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | 709.47 Mn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | 1.93 Bn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 1.64 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Bn |
| Mar 31, 2026 | 1.64 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 30, 2025 | 1.63 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.58 Bn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.52 Bn |
| Mar 31, 2024 | 1.42 Bn |
| Dec 31, 2023 | 1.32 Bn |
| Sep 30, 2023 | 1.18 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 925.40 Mn |
| Dec 31, 2022 | 845.95 Mn |
| Sep 30, 2022 | 681.91 Mn |
| Jun 30, 2022 | 633.10 Mn |
| Mar 31, 2022 | 624.67 Mn |
| Dec 31, 2021 | 587.61 Mn |
| Sep 30, 2021 | 450.79 Mn |